METHYLPHENIDATE ER 45 MG TAB
For 30 tablets
Pharmacies pay
$525.18 filed
30 × $17.50602 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$68.41 filed
30 × $2.28047 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.13× estimated
These two figures may not measure the same thing
At 0.13×, the Medicare figure is 0.2 times what pharmacies pay or less. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.
This product’s middle NADAC price, $17.50602 per EA, is 26.1× the middle NADAC price of the 8 other products CMS averages under “Methylphenidate ER” / “Methylphenidate HCl” ($0.67155 per EA), so the Part D average may mostly describe those products, not this one.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$608.96 estimated
$525.18 + $78.78 (15%) + $5.00 fee per fill = $608.96
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
METHYLPHENIDATE ER 45 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methylphenidate hydrochloride.
FDA gives its dosage form as tablet, extended release and its route as oral.
The labeler, the company named on the label, is Trigen Laboratories, LLC.
FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 13811-0711-30.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $525.18 for 30 tablets (30 × $17.50602 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 13811-0711-30 · Trigen Laboratories, LLC · $17.50602 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
59 other products in the NADAC file share the FDA nonproprietary name methylphenidate hydrochloride with METHYLPHENIDATE ER 45 MG TAB. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CONCERTA ER 18 MG TABLET | $12.32528 per EA filed | We don’t know yet |
| CONCERTA ER 27 MG TABLET | $12.65426 per EA filed | We don’t know yet |
| CONCERTA ER 36 MG TABLET | $13.04275 per EA filed | We don’t know yet |
| CONCERTA ER 54 MG TABLET | $14.17967 per EA filed | We don’t know yet |
| JORNAY PM 20 MG CAPSULE | $15.39302 per EA filed | $15.06416 per EA filed |
| JORNAY PM 40 MG CAPSULE | $15.40511 per EA filed | $15.06416 per EA filed |
| JORNAY PM 60 MG CAPSULE | $15.40191 per EA filed | $15.06416 per EA filed |
| JORNAY PM 80 MG CAPSULE | $15.40151 per EA filed | $15.06416 per EA filed |
| JORNAY PM 100 MG CAPSULE | $15.39596 per EA filed | $15.06416 per EA filed |
| METHYLPHENIDATE ER 10 MG TAB | $0.45832 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 18 MG TAB | $0.5761 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 20 MG TAB | $0.51315 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 27 MG TAB | $0.67661 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 36 MG TAB | $0.67155 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 45 MG TAB this page | $17.50602 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 54 MG TAB | $0.80506 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 63 MG TAB | $18.87437 per EA filed | $2.28047 per EA filed |
| METHYLPHENIDATE ER 72 MG TAB | $16.50883 per EA filed | $2.28047 per EA filed |
| RELEXXII ER 18 MG TABLET | $10.94478 per EA filed | We don’t know yet |
| RELEXXII ER 27 MG TABLET | $11.32467 per EA filed | We don’t know yet |
| RELEXXII ER 36 MG TABLET | $11.74277 per EA filed | We don’t know yet |
| RELEXXII ER 54 MG TABLET | $12.77792 per EA filed | We don’t know yet |
| RELEXXII ER 63 MG TABLET | $21.35259 per EA filed | We don’t know yet |
| RELEXXII ER 72 MG TABLET | $22.0992 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $17.50602 per EA filed.
Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 12 have a higher middle NADAC price and 191 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $68.41 for 30 tablets, at an average of $2.28047 per EA in 2024 (2024-01-01 to 2024-12-31) for “Methylphenidate ER” and “Methylphenidate HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 225,973 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for METHYLPHENIDATE ER 45 MG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: Part D averages every strength and form sold under “Methylphenidate ER” / “Methylphenidate HCl” into one figure, so it is not specific to this NDC. The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Methylphenidate ER / Methylphenidate HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- VYVANSE 10 MG CAPSULE
- DEXTROAMPHETAMINE 10 MG TAB
- BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE
- DEXMETHYLPHENIDATE ER 10 MG CP
- ADDERALL XR 10 MG CAPSULE